Pace Diagnostics is an emerging biotechnology company focused on the research, development, licensing, manufacturing and marketing of cutting-edge diagnostics. Formed, based on the culmination of decades of basic and applied research, supported by grants and contracts from the US Federal Government, our vision is to create breakthrough point-of-care (POC) diagnostics to revolutionize improvements in healthcare for better living. Through our novel, high-throughput platform, and potent biomarkers, we are developing a comprehensive portfolio of POC diagnostics, with our lead developments in Tuberculosis and the early detection of lung cancer.